Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 Restated Certificate of Incorporation, Dated April 22, 2005, As Amended on May 21, 2010, June 22, 2015, August 22, 2019, February 10, 2021, and February 18, 2022
- 3.3 Amended and Restated Certificate of Designation of Series a Preferred Stock, Dated June 22, 2015
- 3.4 Certificate of Designation of Series B Convertible Preferred Stock, Dated July 9, 1998
- 4.2 Amended and Restated Warrant to Purchase Common Stock, Dated March 20, 2020, Issued to BP Peptides, LLC
- 10.6 Third Amendment to Securities Purchase Loan and Security Agreement Dated March 27, 2020, by and Between Capstone Therapeutics, Corp. and BP Peptides, LLC
- 10.7 Fourth Amendment to Securities Purchase Loan and Security Agreement Dated March 15, 2021, by and Between Capstone Therapeutics, Corp. and BP Peptides, LLC
- 10.8 Termination of Securities Purchase, Loan and Security Agreement, Dated November 13, 2024, by and Between Capstone Holding Corp. and BP Peptides, LLC
- 10.10 Fourth Amended and Restated Operating Agreement of Totalstone, LLC, Dated March 27, 2020 and Effective As of November 26, 2021
- 10.11 Consent and First Amendment to the Fourth Amended and Restated Operating Agreement of Totalstone, LLC, Dated March 27, 2020 and Effective As of November 26, 2021
- 10.12 Second Amended and Restated Credit Agreement, Dated March 8, 2023, by and Between Totalstone, LLC, Northeast Masonry Distributors, LLC, Totalstone Properties, LLC, and Stream Finance, LLC
- 10.13 Consent, Waiver and Amendment to Second Amended and Restated Credit Agreement, Dated October 18, 2024, by and Between Totalstone, LLC, Northeast Masonry Distributors, LLC, Totalstone Properties, LLC, and Stream Finance, LLC
- 10.14 Non-negotiable Secured Subordinated Promissory Note by and Between Totalstone, LLC and Northeast Masonry Distributors, LLC
- 10.15 Non-negotiable Secured Subordinated Contingent Value Promissory Note by and Between Nem Purchaser, LLC and Northeast Masonry Distributors, LLC
- 10.16 Brookstone Partners Iac, Inc. Amended and Restated Management Fee Agreement Dated March 1, 2020 by and Between Totalstone, LLC and Brookstone Partners Iac, Inc
- 10.17 Management Fee Agreement, Dated March 27, 2020, by and Between Totalstone, LLC and Capstone Holding Corp
- 10.18 Amendment of Amended and Restated Management Fee and Transaction Fee Agreement, Dated November 15, 2024, by and Between Capstone Holding Corp., Totalstone, LLC, and Brookstone Partners Iac, Inc
- 10.19 Limited Payment Guarantee Dated March 31, 2021, Between Capstone Therapeutics Corp. and Brookstone Acquisition Partners XXI Corporation
- 10.23 Lipimetix Development, Inc. Contingent Value Rights Agreement, Dated August 23, 2019, by and Among Capstone Therapeutics Corp., the Shareholder Representative and Computershare Inc., and Computershare Trust Company, N.a., As Rights Agent
- 10.24 Second Amended and Restated Promissory Note, Dated November 11, 2024, Issued by Capstone Holding Corp. to BP Peptides, LLC
- 10.25 Revolving Credit, Term Loan and Security Agreement by and Among Totalstone, LLC, Northeast Masonry Distributors, LLC, Totalstone Properties, LLC, and Berkshire Bank, Dated December 20, 2017
- 10.26 Amendments to Revolving Credit, Term Loan and Security Agreement Still In Effect As of December 30, 2024
- 10.27 Second Amended and Restated Revolving Credit Note Issued by Totalstone, LLC and Northeast Masonry Distributors, LLC to Berkshire Bank, Dated November 14, 2019
- 10.28 Term Note Issued by Totalstone, LLC, Northeast Masonry Distributors, LLC, and Totalstone Properties, LLC to Berkshire Bank, Dated November 22, 2021
- 10.29 Second Amended and Restated Promissory Note Issued by Capstone Holding Corp. to Brookstone Partners Acquisition XXI Corporation, Dated November 11, 2024
- 21.1 List of Subsidiaries
- 23.1 Consent of GBQ Partners LLC
- 99.1 Consent of Charles Dana to Be Named As a Director Nominee
- 99.2 Consent of Gordon Strout to Be Named As a Director Nominee
- 99.3 Consent of Fredric J. Feldman to Be Named As a Director Nominee
- 99.4 Consent of Elwood D. Howse to Be Named As a Director Nominee
- EX-FILING FEES Filing Fee Table
Associated filings
CAPS similar filings
Filing view
External links